NEU 2.99% $20.10 neuren pharmaceuticals limited

Share Price, page-3847

  1. 2,167 Posts.
    lightbulb Created with Sketch. 571
    I think so, to double from here is not unreasonable expectation considering we already touched $9.08 or something month or so back and the magnitude of value that this upcoming news brings for Neu's future.

    Positive phase 3 trial results were a great milestone no doubt, however as we have all experiencing here is that we are not fully de risked until FDA approve and the asset becomes commercial $$$$$$$$$$$$$$$$$$$$$$$

    By far the biggest Ann for Neu, we know the result for the share price if we are unsuccessful with FDA approval, it should be of equal significance however in our favour should we be approved in my view.




 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.10
Change
-0.620(2.99%)
Mkt cap ! $2.569B
Open High Low Value Volume
$20.41 $20.45 $19.92 $5.947M 296.0K

Buyers (Bids)

No. Vol. Price($)
1 999 $20.10
 

Sellers (Offers)

Price($) Vol. No.
$20.19 10 1
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.